Connective Tissue DiseasesNCT07117552
Study for Patients With Connective Tissue Diseases Who Suffer From Pleuropulmonary Symptoms Clinically and Radiologically
An observational study of Connective Tissue Diseases, run by Sohag University at 1 site in Egypt.
Trial summary
Study for clinical and radiological presentation of patients with connective tissue diseases who complain from pleuropulmonary symptoms Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Connective Tissue Diseases
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Sep 2025to 30 Oct 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with connective tissue disease Presented by pleuropulmonary symptoms
Who may be able to join
- Patients who have diagnosed as connective tissue disease Presented by pleuropulmonary affection
Who cannot join
- Patients who presented by pleuropulmonary affection due to disease other than connective tissue diseases
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Clinical and Radiological Pattern of Pleuropulmonary Affection in Patients With Connective Tissue Diseases
Study for clinical and radiological presentation of patients with connective tissue diseases who complain from pleuropulmonary symptoms
- Conditions
- Connective Tissue Diseases
- Keywords
- Connective tissue diseases, Pulmonary affection, Pulmonary complications
- Medical subject headings
- Connective Tissue Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
assess clinical presentation and radiological pattern of pleuropulmonary affection in patients with connective tissue diseases, and evaluate their effect in outcome of connective tissue diseases
Measured: Day 1 admission
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Aug 2025
- Study start1 Sep 2025 (estimated)
- Primary completion30 Sep 2025 (estimated)
- Study completion30 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Connective Tissue DiseasesStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Abdelrahman Amer Abdelwahab, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07117552
- Sponsor's protocol ID
- soh-med--25-7-3MS
- Status last verified
- Jul 2025
- First submitted
- 1 Aug 2025
- Last updated
- 12 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Radiological Pattern of Pleuropulmonary Affection in Patients With Connective Tissue Diseases
- ClinicalTrials.gov ID
- NCT07117552
- Acronym / sponsor ID
- soh-med--25-7-3MS
- Conditions
- Connective Tissue Diseases
- Keywords
- Connective tissue diseases, Pulmonary affection, Pulmonary complications
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Sep 2025 (estimated)
- Primary completion
- 30 Sep 2025 (estimated)
- Study completion
- 30 Oct 2025 (estimated)
- First posted
- 12 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Study for clinical and radiological presentation of patients with connective tissue diseases who complain from pleuropulmonary symptoms
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with connective tissue disease Presented by pleuropulmonary symptoms
Key inclusion criteria (1 listed)
- Patients who have diagnosed as connective tissue disease Presented by pleuropulmonary affection
Key exclusion criteria (1 listed)
- Patients who presented by pleuropulmonary affection due to disease other than connective tissue diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
assess clinical presentation and radiological pattern of pleuropulmonary affection in patients with connective tissue diseases, and evaluate their effect in outcome of connective tissue diseases
Time frame: Day 1 admission
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2025.
Related trials for Connective Tissue Diseases
RecruitingObservational study
Registry of Ehlers-Danlos Syndrome
Ehlers-Danlos Syndrome
RecruitingObservational study
Cancer in Inherited Bone Marrow Failure Syndromes
Diamond Blackfan Anemia, Dyskeratosis Congenita
RecruitingObservational study
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Breast Cancer, Breast Carcinoma
Not yet recruitingPhase 1
A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer
Advanced or Metastatic Breast Cancer
Not yet recruitingPhase 2
Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC Therapy
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Connective Tissue Diseases, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
assess clinical presentation and radiological pattern of pleuropulmonary affection in patients with connective tissue diseases, and evaluate their effect in outcome of connective tissue diseases (time frame: Day 1 admission). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.